Stockholders' Equity | Stockholders’ Equity The changes in stockholders’ equity for the prior year comparable period is as follows: Common Stock (dollars in thousands) Shares Amount Additional Accumulated Accumulated Total Balance at September 30, 2019 33,687,115 $ 34 $ 242,686 $ (7,973) $ (118,572) $ 116,175 Net loss — — — — (5,196) (5,196) Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units 283,164 — 2 — — 2 Taxes paid associated with net settlement of stock compensation awards (67,688) — (498) — — (498) Forfeitures of restricted stock awards (15,000) — — — — — Stock compensation expense — — 1,121 — — 1,121 Foreign currency translation — — — 833 — 833 Balance at December 31, 2019 33,887,591 $ 34 $ 243,311 $ (7,140) $ (123,768) $ 112,437 Net loss — — — — (4,238) (4,238) Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units 111,272 — 32 — — 32 Taxes paid associated with net settlement of stock compensation awards (10,065) — (60) — — (60) Stock compensation expense — — 1,244 — — 1,244 Foreign currency translation — — — (1,303) — (1,303) Balance at March 31, 2020 33,988,798 $ 34 $ 244,527 $ (8,443) $ (128,006) $ 108,112 Net income — — — — 213 213 Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units 34,185 — 1 — — 1 Taxes paid associated with net settlement of stock compensation awards (1,210) — (6) — — (6) Stock compensation expense — — 1,494 — — 1,494 Foreign currency translation and other — — — 424 — 424 Balance at June 30, 2020 34,021,773 $ 34 $ 246,016 $ (8,019) $ (127,793) $ 110,238 Stock Compensation Incentive Plans The Company has several incentive plans under which stock options, restricted stock units (RSUs), restricted stock awards (RSAs), and cash-settled stock appreciation rights (SARs) have been issued, including the Third Amended and Restated 2006 Omnibus Long-Term Incentive Plan, as amended, and a plan and private placement issuances related to the Company’s acquisition of Machinio. As of June 30, 2021, the Company has reserved at total of 19,100,000 shares of its common stock for exercises of stock options, vesting of RSUs, and grants of RSAs under these plans. Vesting of RSUs and grants of RSAs count as 1.5x shares against the plan reserves. As of June 30, 2021, 1,901,415 shares of common stock remained available for use. Stock Compensation Expense The table below presents the components of share-based compensation expense (in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2021 2020 2021 2020 Equity-classified awards: Stock options $ 762 $ 546 $ 2,491 $ 1,523 RSUs & RSAs 763 948 2,357 2,337 Total equity-classified awards $ 1,525 $ 1,494 $ 4,848 $ 3,860 Liability-classified awards: SARs 278 22 945 (75) Total stock compensation expense: $ 1,803 $ 1,516 $ 5,793 $ 3,785 Stock Options and RSUs & RSAs The following table presents stock option and RSUs & RSAs grant activity: Nine Months Ended June 30, 2021 Stock Options granted: Options containing only service conditions: 558,673 Weighted average exercise price $ 10.69 Weighted average grant date fair value $ 4.49 Options containing performance or market conditions: 549,600 Weighted average exercise price $ 10.51 Weighted average grant date fair value $ 4.34 RSUs & RSAs granted: RSUs & RSAs containing only service conditions: 139,945 Weighted average grant date fair value $ 13.48 RSUs & RSAs containing performance or market conditions: 139,600 Weighted average grant date fair value $ 9.22 The stock options and RSUs & RSAs containing only service conditions will vest over a four-year service period. The stock options and RSUs & RSAs containing performance conditions will vest upon the achievement of specified financial targets of the Company or its segments. The stock options and RSUs & RSAs containing market conditions will vest upon the achievement of specified increases in the Company’s share price. Vesting is measured the first day of each fiscal quarter over the four-year terms of the awards, starting with the first fiscal quarter after the first anniversary of the grant date, based upon the trailing 20-days average of the Company’s share price. The range of assumptions used to determine the fair value of stock options containing only service conditions using the Black-Sc holes option-pricing model during the nine months ended June 30, 2021 were as follows: Nine Months Ended June 30, 2021 Dividend yield — Expected volatility 51.0% - 55.9% Risk-free interest rate 0.4% - 0.8% Expected term 4.6 - 7.6 years The range of assumptions used to determine the fair value of stock options and RSUs & RSAs containing market conditions using Monte Carlo simulations during the nine months ended June 30, 2021 were as follows: Nine Months Ended June 30, 2021 Dividend yield — Expected volatility 51.6% - 54.6% Risk-free interest rate 0.3% - 0.9% Expected holding period (% of remaining term) 31.7% - 100.0% SARs During the nine months ended June 30, 2021, the Company did not issue any SARs, 43,959 SARs were exercised requiring the Company to make cash payments of $0.4 million, and 73,681 SARs were canceled. As of June 30, 2021 , 43,170 SARs were outstanding. Share Repurchase Program We are authorized to repurchase issued and outstanding shares of our common stock under a share repurchase program approved by our Board of Directors. Share repurchases may be made through open market purchases, privately negotiated transactions or otherwise, at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase program may be discontinued or suspended at any time and will be funded using our available cash. As of the fiscal year ended September 30, 2020, we had $6.1 million of remaining share repurchase authorization. On March 8, 2021, our Board of Directors authorized an additional $10 million of share repurchases of the Company's outstanding shares of common stock through March 31, 2023. We repurchased 647,583 shares for $12.0 million and 957,079 shares for $16.1 million under this program during the three and six months ended March 31, 2021 , respectively. As of March 31, 2021 , we had no remaining authorization to repurchase shares under these programs. On May 3, 2021, the Company's Board of Directors authorized a new stock repurchase plan (the “May 3, 2021 Stock Repurchase Plan”) of up to $15 million of our outstanding shares of common stock through June 30, 2023. We made no repurchases under the May 3, 2021 Stock Repurchase Plan during the three months ended June 30, 2021. Other Share Repurchases Separate from the share repurchase program, our stock incentive plans allow for participants to exercise stock options by surrendering shares of common stock equivalent in value to the exercise price due. During the three months ended June 30, 2021, no shares of common stock were surrendered by participants in the exercise of stock options. During the nine months ended June 30, 2021, participants surrendered 82,612 shares of common stock in the exercise of stock options . Any shares surrendered to the Company in this manner are not available for future grant. |